6640--Specimen Validity and Drug of Abuse of Abuse Reagent Supplies for the Minneapolis VA Health Care System
Closed Pre-Solicitation Posted
Not the latest version. See the latest special notice from .
- Solicitation number
- 36C26326Q0650
- Agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Department of Veteran Affairs Minneapolis VA Health Care System Minneapolis, Minnesota 55417, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs, Veterans Health Administration, Veterans Integrated Service Network 23 is conducting market research for specimen validity and drug of abuse reagent supplies to support the Minneapolis VA Health Care System's Forensic Toxicology Laboratory, with responses due May 7, 2026. This is a sources sought notice; no contract award will be made from this announcement.
The anticipated contract is a five-year, brand-name-only award effective October 1, 2026, through September 30, 2031, on an on-demand, as-needed basis limited to Minneapolis VA Health Care System use. Required supplies include Creatinine Perfect reagent, Fentanyl reagent, Nitrite Perfect reagent, calibrators, and validity calibrators, with estimated annual quantities ranging from 6 to 25 units per product. All items must be FDA-approved.
Delivery must occur within five calendar days of order placement to the VA Medical Center warehouse in Minneapolis, between 8:00 AM and 3:30 PM Monday through Friday. Technical support must be available Monday through Friday, 8:00 AM to 5:00 PM, with telephone response within four hours.
Vendors must submit responses via email to theresa.thunder@va.gov and provide socio-economic category, proof of capability or authorized distributor status with manufacturer information, country of origin certification per FAR 52.225-2(b), information on existing government contracts, small business compliance documentation per 13 CFR 121.406, and estimated shipping and delivery lead times. Failure to respond to required questions may affect acquisition strategy.
Notice text
The Minneapolis Health Care System requires Specimen Validity and Drug of Abuse Reagen Supplies with the Salient Characteristics listed below.
This is a sources sought looking for businesses to provide the supplies listed below for market research purposes. No awards of a contract will be made from this announcement.
If you are a vendor that can provide the requested information above and required supplies described below with competitive pricing, send your information (to include your organization's Unique Entity Identifier number) with a description of proof of capability to: theresa.thunder@va.gov on or before May 7th, 2026. Only emailed responses will be considered.
Additionally, please provide answers as appropriate to the following questions in the table below with your response to this sources sought. Failure to respond to the following questions may affect the acquisition strategy.
1.
Identify your organization's socio-economic category.
2.
Identify if your organization is the manufacturer of the requested supplies. If you are not the manufacturer, identify the manufacturer of the supplies that you will provide, their socio-economic category and a letter showing that your organization is an authorized distributor for the requested supplies.Â
3.
Fill out the certificate under FAR Provision 52.225-2(b), identifying the item and its country of origin. ( https://www.acquisition.gov/far/part-52#FAR_52_225_2__d3401e52). If the product is a US domestic end product, write in USA for the item's country of origin.
4.
State whether any of the requested supplies may be ordered against a government contract awarded to your organization (e.g Federal Supply Schedule (FSS), General Services Administration (GSA), etc.).
5.
Address whether your organization meets the requirements of 13 CFR 121.406 (b)(1)(i), (b)(1)(ii) and (b)(1)(iii) (https://www.ecfr.gov/current/title-13/chapter-I/part-121/subpart-A/subject-group-ECFR0fca5207262de47/section-121.406#p-121.406(b)).
6.
Provide estimated shipping and delivery information for the requested supplies (e.g. Expected lead time on delivery).
Â
*If applicable, VAAR 852.219-76 VA Notice of Limitations on Subcontracting Certificate of Compliance for Supplies and Products, will apply to the potential solicitation if set-aside for Veteran Owned Small-Businesses.*
Â
*If applicable, VAAR 852.212-71 Gray Market Items, will apply to the potential solicitation.*
*If applicable, FAR 52.219-14 Limitations on Subcontracting, will apply to the potential solicitation if set-aside for Small-Businesses. *
Files
| File | Type | Posted |
|---|---|---|
| 36C26326Q0650.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6640--Specimen Validity and Drug of Abuse of Abuse Reagent Supplies for the Minneapolis VA Health Care System | Special Notice | |
| This notice | Pre-Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity